EARNEST Partners’s Anika Therapeutics ANIK Stock Holding History

EARNEST Partners’s Portfolio ANIK Stock Details ANIK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,500	Closed	-$27.9K	–	336
2023 Q3	$27.9K	Hold	1,500	–	–	﹤0.01%	438
2023 Q2	$39K	Hold	1,500	–	–	﹤0.01%	374
2023 Q1	$43.1K	Hold	1,500	–	–	﹤0.01%	358
2022 Q4	$44.4K	Hold	1,500	–	–	﹤0.01%	354
2022 Q3	$36K	Hold	1,500	–	–	﹤0.01%	356
2022 Q2	$33K	Hold	1,500	–	–	﹤0.01%	377
2022 Q1	$38K	Hold	1,500	–	–	﹤0.01%	370
2021 Q4	$54K	Hold	1,500	–	–	﹤0.01%	333
2021 Q3	$64K	Hold	1,500	–	–	﹤0.01%	319
2021 Q2	$65K	Hold	1,500	–	–	﹤0.01%	319
2021 Q1	$61K	Hold	1,500	–	–	﹤0.01%	317
2020 Q4	$68K	Hold	1,500	–	–	﹤0.01%	300
2020 Q3	$53K	Hold	1,500	–	–	﹤0.01%	305
2020 Q2	$57K	Hold	1,500	–	–	﹤0.01%	292
2020 Q1	$43K	Hold	1,500	–	–	﹤0.01%	304
2019 Q4	$78K	Hold	1,500	–	–	﹤0.01%	278
2019 Q3	$82K	Hold	1,500	–	–	﹤0.01%	277
2019 Q2	$61K	Hold	1,500	–	–	﹤0.01%	297
2019 Q1	$45K	Hold	1,500	–	–	﹤0.01%	325
2018 Q4	$50K	Hold	1,500	–	–	﹤0.01%	296
2018 Q3	$63K	Hold	1,500	–	–	﹤0.01%	293
2018 Q2	$48K	Hold	1,500	–	–	﹤0.01%	316
2018 Q1	$75K	Hold	1,500	–	–	﹤0.01%	276
2017 Q4	$81K	Buy	+1,500	New	+$81K	﹤0.01%	263
2017 Q1	–	Sell	-1,500	Closed	-$73K	–	278
2016 Q4	$73K	Hold	1,500	–	–	﹤0.01%	258
2016 Q3	$72K	Hold	1,500	–	–	﹤0.01%	236
2016 Q2	$80K	Hold	1,500	–	–	﹤0.01%	238
2016 Q1	$67K	Hold	1,500	–	–	﹤0.01%	246
2015 Q4	$57K	Hold	1,500	–	–	﹤0.01%	244
2015 Q3	$48K	Hold	1,500	–	–	﹤0.01%	244
2015 Q2	$50K	Hold	1,500	–	–	﹤0.01%	242
2015 Q1	$62K	Hold	1,500	–	–	﹤0.01%	233
2014 Q4	$61K	Hold	1,500	–	–	﹤0.01%	239
2014 Q3	$55K	Hold	1,500	–	–	﹤0.01%	230
2014 Q2	$69K	Hold	1,500	–	–	﹤0.01%	236
2014 Q1	$62K	Sell	1,500 -600	-29%	-$24.8K	﹤0.01%	238
2013 Q4	$80K	Buy	+2,100	New	+$80K	﹤0.01%	243